About this trial
Determine 1) the impact of abnormal fetal cerebrovascular physiology with neurodevelopmental delay (ND) outcomes and 2) how this relationship is modified by patient and environmental factors such as chronic congenital heart disease (CCHD) lesion, maternal-fetal environment, and social determinants of heath (SDOH) in a diverse population using a multicenter design.
Pregnant women will be approached during one of their fetal cardiology clinic visits.
Eligibility criteria
Qualifiers
Pregnant women 18 years of age and over with a singleton fetus with known or suspected congenital heart disease anticipated to need intervention or surgery within 30 days of birth.
Disqualifiers
Known fetal chromosomal or genetic abnormalities
Multiple gestation pregnancy
Fetal extra-cardiac anomalies
Trial design
Treatments tested in this trial
- Single Arm
- Neonatal Neurobehavioral Scale
Treatment groups
Sponsors and collaborators
University of Utah
Lead sponsor
Primary Children's Hospital
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator